Skip to content
★ Sign in to follow
JP

John P. Devine

Executive
Inotiv, Inc.
Total declarations
5
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€12k

Latest filing published 26 Aug 2014 for Inotiv, Inc., €1,914.

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

No signal scores available.

John P. Devine: trading record in brief

John P. Devine discloses dealings in Inotiv, Inc. to SEC (Form 4). The record holds 5 filings, for trades running from 3 March 2014 to 25 August 2014.

No open-market purchase appears, only 2 sales worth €12k. Outside the open market, there are 1 share grant and 2 option exercises.

On 26 August 2014 came the latest disclosure, an option exercise for €1,914 in Inotiv, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 6 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to John P. Devine

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◇
    VP--ToxicologyExecutivesInotiv, Inc.
    2,525 USD0SEC
    2,500 shares@ US$1.01Common StockSEC:0001179110-14-013289:0
  • ◇
    VP--ToxicologyExecutivesInotiv, Inc.
    5,050 USD0SEC
    5,000 shares@ US$1.01Common StockSEC:0001179110-14-010536:0
  • ◆
    VP--ToxicologyExecutivesInotiv, Inc.
    5,049 USD0SEC
    1,870 shares@ US$2.70Common StockSEC:0001179110-14-010536:1
  • ▼
    VP--ToxicologyExecutivesInotiv, Inc.
    8,263 USD0SEC
    3,130 shares@ US$2.64Common StockSEC:0001179110-14-010536:2

4 of 4 declarations